Cleared Special

K250283 - RAP Femoral Venous Cannulae (FDA 510(k) Clearance)

Jul 2025
Decision
160d
Days
Class 2
Risk

K250283 is an FDA 510(k) clearance for the RAP Femoral Venous Cannulae. This device is classified as a Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass (Class II - Special Controls, product code DWF).

Submitted by LivaNova USA, Inc. (Arvada, US). The FDA issued a Cleared decision on July 10, 2025, 160 days after receiving the submission on January 31, 2025.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.4210.

Submission Details

510(k) Number K250283 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 31, 2025
Decision Date July 10, 2025
Days to Decision 160 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code DWF — Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.4210

Similar Devices — DWF Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass

All 11
Retrograde Coronary Sinus Perfusion Cannulae
K253203 · Medtronic, Inc. · Feb 2026
Dual Stage Venous Cannulae
K253671 · Sorin Group Italia S.R.L. · Jan 2026
Clearview Intracoronary Shunts
K253998 · Medtronic, Inc. · Jan 2026
AngioVac Cannula
K253106 · AngioDynamics, Inc. · Oct 2025
Easyflow (103-200
K250610 · Sorin Group Italia S.R.L. · Jun 2025
MC2™ Two-Stage Venous Cannula
K251258 · Medtronic, Inc. · Jun 2025